Researchers at Tufts University School of Medicine and the Graduate School of Biomedical Sciences (GSBS) have identified a small molecule that, in mouse and human cell models, rectifies the underlying molecular cause of a rare genetic developmental disorder, CTNNB1 syndrome, linked with motor and intellectual disabilities and some types of autism spectrum disorder. 

Read More